文献速递膀胱癌与上尿路尿路上皮癌

当代浸润性上尿路尿路上皮癌的发病率和生存率

Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
PubMed 文献 · Eur Urol Oncol · 2020-12-05

非转移性患者行根治性肾输尿管切除术,分期、分级、年龄和性别是癌症特异性死亡的独立预测因素;转移性患者中化疗、根治性手术和输尿管原发与更低总死亡风险相关。

要点

  • UTUC总体发病率下降,但转移性UTUC发病率上升。
  • 非转移性UTUC中T3N0M0、T4N0M0和T1-4N1-2M0分别占28.9%、4.6%和10.0%。
  • 转移性UTUC中化疗和根治性肾输尿管切除术对总死亡有保护作用,输尿管原发预后更好。

核心结论

  • UTUC总体年龄标化发病率下降,但转移性UTUC发病率上升。

主要发现

  • UTUC总体年龄标化发病率从1.3降至1.1例/10万人年(平均年度百分比变化-1.32%,p=0.002)。
  • T1-2N0M0期年龄标化发病率下降(平均年度百分比变化-2.77%,p<0.001),而T1-4N0-2M1期上升(平均年度百分比变化+2.87%,p<0.01)。
  • 非转移性UTUC行根治性肾输尿管切除术后,分期、分级、年龄和性别是癌症特异性死亡的独立预测因素(p<0.001)。
  • 转移性UTUC中,化疗、根治性肾输尿管切除术和输尿管原发是总死亡更低的独立预测因素。

关键数值与推荐

  • 非转移性UTUC中T3N0M0、T4N0M0和T1-4N1-2M0分别占所有发病病例的28.9%、4.6%和10.0%。

临床怎么用

  • 转移性UTUC患者可考虑化疗和根治性肾输尿管切除术以改善总生存。
  • 输尿管原发转移性UTUC患者生存预后更好。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Contemporary incidence and mortality rates of upper tract urothelial carcinoma (UTUC) are unavailable. OBJECTIVE: To describe contemporary UTUC incidence and mortality rates in the USA. DESIGN, SETTING, AND PARTICIPANTS: Within the Surveillance, Epidemiology and End Results (SEER) database (2004-2016), we identified 13 075 UTUC patients. Of all, 9208 (70.4%) harbored nonmetastatic UTUC and were treated with radical nephroureterectomy versus 1174 (9.0%) who harbored metastatic UTUC. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Age-standardized incidence rates per 100 000 person years were calculated. Kaplan-Meier curves and multivariable Cox regression models addressed cancer-specific and overall mortality. RESULTS AND LIMITATIONS: Overall UTUC age-standardized incidence rates decreased from 1.3 to 1.1 cases per 100 000 person years (average annual percentage change: -1.32%, p = 0.002). Moreover, age-standardized incidence rates decreased for T1-2N0M0 (average annual percentage change: -2.77%, p < 0.001) but increased for T1-4N0-2M1 stage (average annual percentage change: +2.87%, p < 0.01). In nonmetastatic UTUC treated with radical nephroureterectomy, stage, grade, age, and sex (p < 0.001) were independent predictors in multivariable Cox regression models focusing on cancer-specific mortality. In metastatic UTUC, chemotherapy administration, radical nephroureterectomy treatment, and ureteral primary were independent predictors of lower overall mortality in multivariable Cox regression models. CONCLUSIONS: Although overall incidence of UTUC decreased, the incidence of metastatic UTUC increased over the study period. The majority of nonmetastatic UTUC harbored T1N0M0 stage. However, T3N0M0, T4N0M0, and T1-4N1-2M0 stages, respectively, affected 28.9%, 4.6%, and 10.0% of all incident cases. In metastatic UTUC, both chemotherapy and radical nephroureterectomy use exerted an important protective effect on overall mortality, and ureteral primaries exhibited more favorable survival. PATIENT SUMMARY: From 2004 to 2016, the incidence of upper tract urothelial carcinoma decreased in the USA. However, more advanced stages are on the rise.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Collà Ruvolo C, Nocera L, Stolzenbach LF, et al. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma. Eur Urol Oncol. 2020. PMID: 33293235. doi:10.1016/j.euo.2020.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。